Human cell-based estrogen receptor beta dimerization assay.

[1]  K. Yoon,et al.  An In vitro dimerization assay for the adverse outcome pathway approach in risk assessment of human estrogen receptor α-mediated endocrine-disrupting chemicals , 2022, Chemosphere.

[2]  K. Ko,et al.  Development of a Human Estrogen Receptor Dimerization Assay for the Estrogenic Endocrine-Disrupting Chemicals Using Bioluminescence Resonance Energy Transfer , 2021, International journal of environmental research and public health.

[3]  James H. Liu.  Selective estrogen receptor modulators (SERMS): keys to understanding their function , 2020, Menopause.

[4]  M. Beato,et al.  Signaling by Steroid Hormones in the 3D Nuclear Space , 2018, International journal of molecular sciences.

[5]  M. Muyan,et al.  Molecular mechanism of estrogen–estrogen receptor signaling , 2016, Reproductive medicine and biology.

[6]  G. Shulman,et al.  17α-Estradiol Alleviates Age-related Metabolic and Inflammatory Dysfunction in Male Mice Without Inducing Feminization , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

[7]  K. Dahlman-Wright,et al.  Estrogen receptor alpha and beta in health and disease. , 2015, Best practice & research. Clinical endocrinology & metabolism.

[8]  Yan Li,et al.  microRNA-206 overexpression inhibits cellular proliferation and invasion of estrogen receptor α-positive ovarian cancer cells. , 2014, Molecular medicine reports.

[9]  J. Gustafsson,et al.  Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer , 2014, Proceedings of the National Academy of Sciences.

[10]  F. Soares,et al.  Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness–a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer , 2013, BMC Cancer.

[11]  Kyung-Chul Choi,et al.  Functions and physiological roles of two types of estrogen receptors, ERα and ERβ, identified by estrogen receptor knockout mouse , 2012, Laboratory animal research.

[12]  Lorenzo Ferraro,et al.  Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation , 2011, BMC Genomics.

[13]  D. F. Skafar,et al.  The multifunctional estrogen receptor-alpha F domain , 2008, Endocrine.

[14]  P. Ascenzi,et al.  Estrogen signaling multiple pathways to impact gene transcription. , 2006, Current genomics.

[15]  B. Zhu,et al.  Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: Insights into the structural determinants favoring a differential subtype binding. , 2006, Endocrinology.

[16]  Rainer Bischoff,et al.  Receptor-ligand binding assays: technologies and applications. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[17]  M. Iida,et al.  Differential effects of phthalate esters on transcriptional activities via human estrogen receptors α and β, and androgen receptor , 2005 .

[18]  B. O’Malley.  A life-long search for the molecular pathways of steroid hormone action. , 2005, Molecular endocrinology.

[19]  E. Lam,et al.  Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation. , 2003, Oncogene.

[20]  G. Clark,et al.  Assessing estrogenic activity of phytochemicals using transcriptional activation and immature mouse uterotrophic responses. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[21]  B. van der Burg,et al.  Estrogenic activity of UV filters determined by an in vitro reporter gene assay and an in vivo transgenic zebrafish assay , 2002, Archives of Toxicology.

[22]  Richard E. White.  Estrogen and vascular function. , 2002, Vascular pharmacology.

[23]  S. Yoo,et al.  Potential estrogenic effects of bisphenol-A estimated by in vitro and in vivo combination assays. , 2001, The Journal of toxicological sciences.

[24]  S. Inoue,et al.  Clinical value of the wild-type estrogen receptor β expression in breast cancer , 2001 .

[25]  T. Zacharewski,et al.  In Vitro and in Vivo Interactions of Bisphenol A and Its Metabolite, Bisphenol A Glucuronide, with Estrogen Receptors α and β , 2001 .

[26]  F. Gannon,et al.  Identification of a new isoform of the human estrogen receptor‐alpha (hER‐α) that is encoded by distinct transcripts and that is able to repress hER‐α activation function 1 , 2000 .

[27]  J. Corton,et al.  Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β. , 1998, Endocrinology.

[28]  J. Lehmann,et al.  Cloning and Characterization of Human Estrogen Receptor β Isoforms , 1998 .

[29]  S. Cowley,et al.  Estrogen Receptors α and β Form Heterodimers on DNA* , 1997, The Journal of Biological Chemistry.

[30]  J. Leatherland,et al.  Metabolism of estrogens and androgens by embryonic tissues of Arctic charr, Salvelinus alpinus. , 1997, General and comparative endocrinology.

[31]  K. Grandien,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors � and � , 2022 .

[32]  D. Kaufman,et al.  Antagonistic and agonistic effects of tamoxifen: significance in human cancer. , 1997, Seminars in oncology.

[33]  J. Gorski,et al.  The role of ligand in estrogen receptor regulation of gene expression , 1991, Molecular and Cellular Endocrinology.